Novità in dislipidemiaUltimo aggiornamento: Martedì 02 Marzo 2021

Saba Soltani et al. | Phytotherapy Research 2021; AOP: 10.1002/ptr.6991...
Hypercholesterolemia is a major cardiovascular disease (CVD) risk factor (Lopez, Mathers, Ezzati, Jamison,...
Andrey V. Susekov   et al. | Cardiovascular Drugs and Therapy 2021;...
Elevated plasma low-density lipoprotein cholesterol (LDL-C) is a major modifiable risk factor for atherosclerotic...
Cicero, Arrigo F.G. et al. | Journal of the American College of Cardiology...
The extracts of red yeast rice (RYR) are currently the most effective cholesterol-lowering nutraceuticals....
Anderson, Josephine L.C. et al. | Journal of clinical lipidology 2021;...
Transplant vasculopathy (TV) is a major contributing factor to chronic graft failure in renal transplant...
Ciardullo, Stefano et al. | Nutrition, Metabolism and Cardiovascular...
Seasonal variations in several risk factors for cardiovascular events (CVD) were described. Here, we...
Bolek, Tomas et al. | Blood Coagulation & Fibrinolysis 2021;...
Long-term direct oral anticoagulants (DOACs), including direct thrombin inhibitor dabigatran, should...
Capucine Bertrand et al. | Diabetologia 2021; 64(3): 668-80
Lower-limb peripheral artery disease (PAD) is an emerging public health burden with an endemic progression...
Zhang, Ruiying et al. | The American Journal of Cardiology 2021;...
Patients with homozygous familial hypercholesterolemia (HoFH) have a high risk for premature death. Supravalvular...
Lorenzo Cristina et al. | Nature 2021; 589(7841): 287-92
Atherosclerosis is a chronic inflammatory disease that leads to the formation of atheroma plaques in...
Sánchez, et al. | Journal of clinical lipidology 2021;...
Familial hypercholesterolemia (FH) is an inherited disorder mainly caused by mutations in the LDL receptor...

Ricerca bibliograficaConcentrati e scegli la tua ricerca di dati scientifici

Ricerca per revisione
631 articoli attualmente disponibili
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9

Top articlesArticoli più letti

Bolek, Tomas et al. | Blood Coagulation & Fibrinolysis 2021;...
Long-term direct oral anticoagulants (DOACs), including direct thrombin inhibitor dabigatran, should be preferred to prevent stroke and systemic embolism in patients with atrial fibrillation [1]. In addition,...
Andrey V. Susekov   et al. | Cardiovascular Drugs and Therapy 2021;...
Elevated plasma low-density lipoprotein cholesterol (LDL-C) is a major modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD) [1,2,3,4]. Statins (3-hydroxy-3-methylglutaryl coenzyme...
Capucine Bertrand et al. | Diabetologia 2021; 64(3): 668-80
Lower-limb peripheral artery disease (PAD) is an emerging public health burden with an endemic progression worldwide resulting from demographic expansion, population ageing and growing prevalence of type...
Cicero, Arrigo F.G. et al. | Journal of the American College of Cardiology...
The extracts of red yeast rice (RYR) are currently the most effective cholesterol-lowering nutraceuticals. This activity is mainly due to monacolin K, a weak reversible inhibitor of 3-hydroxy-3-methyl-glutaryl-co...
Lorenzo Cristina et al. | Nature 2021; 589(7841): 287-92
Atherosclerosis is a chronic inflammatory disease that leads to the formation of atheroma plaques in the arteries and is the main underlying cause of thrombosis, ischaemic heart disease and stroke6. The...